F-group (family)
206.1.1.28 Haspin_kinase
Ligands and drugs
82
Member domains
37
with ligand contacts (≤ 4 Å)
45.1% of members
29
with DrugDomain annotations
35.4% of members
28
with a DrugBank compound
34.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 206.1.1.28 belongs to X-group 206 Protein kinase/SAICAR synthase/ATP-grasp, which binds 10.2 ligand superclasses per 20 proteins, broader than 96% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB04604 | 5ID | 5-iodotubercidin | 6 |
| DB00139 | SIN | Succinic acid | 3 |
| DB00131 | AMP | Adenosine phosphate | 1 |
| DB03172 | TBN | Tubercidin | 1 |
| DB07698 | DZO | 3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine | 1 |
| DB07995 | IQB | H-89 | 1 |
| DB08004 | IZZ | (2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAmetal | SODIUM ION | 17 |
| NImetal | NICKEL (II) ION | 7 |
| 5ID | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL | 6 |
| IOD | IODIDE ION | 6 |
| MRD | (4R)-2-METHYLPENTANE-2,4-DIOL | 3 |
| SIN | SUCCINIC ACID | 3 |
| COmetal | COBALT (II) ION | 2 |
| ZNmetal | ZINC ION | 2 |
| 07C | 2-methylsulfanyl-10-nitro-pyrido[3,4-g]quinazoline | 1 |
| 38Z | (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide | 1 |
| 66M | (2R)-2-{[6-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]carbonyl}amino)hexanoyl]amino}butanedioic acid (non-preferred name) | 1 |
| 6L5 | (3R)-4-amino-3-{[6-({[(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]carbonyl}amino)hexanoyl]amino}-4-oxobutanoic acid (non-preferred name) | 1 |
| A1IDA | 5-(1-methylpyrazol-3-yl)-3-pyridin-4-yl-thieno[3,2-b]pyridine | 1 |
| A1IDB | 5-(1-methylpyrazol-4-yl)-3-pyridin-4-yl-thieno[3,2-b]pyridine | 1 |
| A1IDC | ~{N}-(1,4-dimethylpyrazol-3-yl)-3-(1,2-thiazol-5-yl)thieno[3,2-b]pyridin-5-amine | 1 |
| A1IDD | [4-[5-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]pyridin-2-yl]methanamine | 1 |
| A1IDE | 5-(1-methylpyrazol-4-yl)-3-pyridin-4-yl-1~{H}-pyrazolo[1,5-a]pyrimidine | 1 |
| A1IDF | ~{N}-(1,4-dimethylpyrazol-3-yl)-3-pyridin-4-yl-thieno[3,2-b]pyridin-5-amine | 1 |
| A1MBI | (2~{R},3~{R},4~{S},5~{R})-2-(4-azanyl-5-ethynyl-pyrrolo[2,3-d]pyrimidin-7-yl)-5-[[(azanylidene-$l^{4}-azanylidene)amino]methyl]thiolane-3,4-diol | 1 |
| A5G | 1-[(4S)-5-(2,4-difluorophenyl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-4-methylpiperidin-4-amine | 1 |